Clinical Trial Update: Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating opioid reduction during outpatient pediatric urologic procedures using Exparel has been terminated; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordee
• Hydrocele
• Hypospadias
• Orchiectomy
• Undescended Testes
• Urologic Diseases

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Urologic Diseases, Hypospadias | Phase 3 | Status: TERMINATED | Results posted: 2023-12-26